Physician profile
Patrick M Fleeman
NPI 1447516216
$4,322.44
in general payments reported to CMS, 2019-2025
17 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $99.21 · 2021: $207 · 2022: $1,459 · 2023: $1,767 · 2024: $277 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Travel and Lodging: $868 · Gift: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.76 |
| Travel and Lodging | $868.23 |
| Gift | $339.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,801.50 | 2022-2024 | Da Vinci Surgical System |
| Braintree Laboratories, INC. | $559.79 | 2021-2023 | Sutab, Suflave |
| Abbvie INC. | $234.40 | 2023-2025 | |
| Medtronic, INC. | $182.99 | 2022-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology |
| Tela Bio, INC. | $117.10 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Amgen INC. | $112.15 | 2019-2020 | |
| Allergan, INC. | $102.55 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $43.55 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $27.43 | 2019 | |
| Pfizer INC. | $23.22 | 2019 | |
| Merck Sharp & Dohme LLC | $20.59 | 2025 | Keytruda, Lynparza |
| Solventum Corporation | $18.78 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| W. L. Gore & Associates, INC. | $17.70 | 2025 | Gore Synecor Biomaterial |
| Osiris Therapeutics INC. | $16.48 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $16.23 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.21 | 2019 | |
| Acera Surgical, INC. | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Fleeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.